[Alternatives in the treatment of rheumatoid arthritis: reasons for using abatacept].

Rheumatoid arthritis (RA) is an aggressive and progressive disease in which the prognosis has improved dramatically since the arrival of biological therapies at the end of the nineties. Nowadays, the main management strategies focus on early diagnosis and treatment, which is now more feasible due to the development of new classification criteria orientated towards diagnosis and classification of early and undifferentiated disease. The implementation of early, individualized and intensive treatment, with the aim of achieving remission or a low disease activity state, has notably improved the results obtained in a great percentage of patients, especially in those with a poorer prognosis. Abatacept is one of the biotechnological agents that have become part of the first line therapeutic armamentarium for early and aggressive RA. The efficacy and safety profile of this drug are very promising for the treatment of patients with RA.
AuthorsS Castañeda, M J Martínez Calatrava, G Herrero-Beaumont
JournalRevista clínica española (Rev Clin Esp) Vol. 212 Issue 5 Pg. 244-54 (May 2012) ISSN: 1578-1860 [Electronic] Spain
Vernacular TitleDisyuntivas en el tratamiento de la artritis reumatoide: razones para el uso de abatacept.
PMID22176928 (Publication Type: English Abstract, Journal Article, Review)
CopyrightCopyright © 2011 Elsevier España, S.L. All rights reserved.
Chemical References
  • Antirheumatic Agents
  • Immunoconjugates
  • Abatacept
  • Abatacept
  • Antirheumatic Agents (therapeutic use)
  • Arthritis, Rheumatoid (diagnosis, drug therapy)
  • Humans
  • Immunoconjugates (therapeutic use)
  • Practice Guidelines as Topic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: